An anticancer fluorescent substance in the human urine. II. Biological properties of an anticancer fluorescent substance
Chen, Y.Q.
Zhonghua Zhong Liu Za Zhi 5(4): 266-269
1983
ISSN/ISBN: 0253-3766 PMID: 6653342 Document Number: 197370
Document emailed within 1 workday
Related Documents
Liu, S.Z. 1983: An anticancer fluorescent substance in the human urine. I. Separation and determination in normal individuals and cancer patients Zhonghua Zhong Liu Za Zhi 5(2): 108-109Yamada, T.; Tanaka, N.; Yokoi, K.; Ishikawa, N.; Seya, T.; Horiba, K.; Kanazawa, Y.; Shirakawa, T.; Ohkawa, K.; Kudoh, H.; Koizumi, M.; Yoshioka, M.; Tajiri, T. 2007: Substance P and anticancer drug-induced emesis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(6): 903-906
Digenis, G.; Hadjivassiliou, A.G.; Mayopoulou-Symvoulidis, D.; Tsaparas, N.; Symvoulidis, A. 1981: The unidentified fluorescent substance(s) in serum of patients with chronic renal failure: correlation with serum creatinine Clinical Chemistry 27(9): 1618-1619
Yoshida, K.; Wago, K. 1981: Studies on the clinical significance of a simple fluorometric determination method of thiobarbituric acid reactive substance levels in human urine--urinary thiobarbituric acid reactive substance levels in hemiplegia and rheumatoid arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 29(1): 87-89
Kruszyński, M.; Kupryszewski, G.; Misterek, K.; Gumułka, S. 1990: Synthesis and some biological properties of the hexapeptide analog of substance P with a C-terminal thioamide group Polish Journal of Pharmacology and Pharmacy 42(5): 483-490
De Angelis, C.; Riscazzi, M.; Salvini, R.; Piccoli, A.; Ferri, C.; Santucci, A. 1997: Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography Clinical Chemistry 43(8 Pt 1): 1416-1420
Okamoto, Y.; Shirotori, K.; Kudo, K.; Ishikawa, K.; Ito, E.; Togawa, K.; Saito, I. 1993: Cytokine expression after the topical administration of substance P to human nasal mucosa. the role of substance P in nasal allergy Journal of Immunology 151(8): 4391-4398
Hagiwara, A.; Takahashi, T. 1987: A new drug-delivery-system of anticancer agents: activated carbon particles adsorbing anticancer agents In Vivo 1(4): 241-252
Landheim, A.S.; Bakken, K.; Vaglum, P. 2006: What characterizes substance abusers who commit suicide attempts? Factors related to Axis i disorders and patterns of substance use disorders. a study of treatment-seeking substance abusers in Norway European Addiction Research 12(2): 102-108
1999: Center for Mental Health Services; Center for Substance Abuse Treatment; fiscal year 1999 funding opportunity. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services (CMHS), Center for Substance Abuse Treatment (CSAT). Notice of availability of funds for cooperative agreements for CMHS/CSAT collaborative program on homeless families: women with psychiatric, substance u Federal register 64(108): 30350-30352
Botvin'ev, O.K.; Atamanova, T.M. 1976: A fluorescent method of determining aldosterone in urine Problemy Endokrinologii 22(3): 44-47
Janssen, M.J.; Hulst, R.; Kellogg, R.M.; Hendriks, M.M.; Ensing, K.; de Zeeuw, R.A. 2000: Fluorescent-labeled ligands for the benzodiazepine receptor. Part 1: Synthesis and characterization of fluorescent-labeled benzodiazepines Die Pharmazie 55(1): 42-48
Yang, M.; Jiang, P.; Hoffman, R.M. 2015: Early Reporting of Apoptosis by Real-time Imaging of Cancer Cells Labeled with Green Fluorescent Protein in the Nucleus and Red Fluorescent Protein in the Cytoplasm Anticancer Research 35(5): 2539-2543
Dubinskaia, V.A.; Nikolaeva, S.S.; Khoroshkov, I.A.; Koroleva, O.A. 1991: The structure and physicochemical properties of human hyaline cartilage in the disorganization of the carbohydrate-protein complexes of the ground substance Biulleten' Eksperimental'noi Biologii i Meditsiny 111(3): 267-269
Shoji, M.; Harigaya, Y.; Okamoto, K.; Yamaguchi, H.; Hirai, S. 1988: The study of neuroactive substance within senile plaques--with special reference to somatostatin and substance P Rinsho Shinkeigaku 28(1): 67-73
Browne, F.A.; Wechsberg, W.M. 2010: The intersecting risks of substance use and HIV risk among substance-using South African men and women Current Opinion in Psychiatry 23(3): 205-209
Farmer, R.F.; Kosty, D.B.; Seeley, J.R.; Gau, J.M.; Klein, D.N. 2019: Family Aggregation of Substance use Disorders: Substance Specific, Nonspecific, and Intrafamilial Sources of Risk Journal of Studies on Alcohol and Drugs 80(4): 462-471
Floyd, L.J.; Hedden, S.; Lawson, A.; Salama, C.; Moleko, A.Gloria.; Latimer, W. 2010: The association between poly-substance use, coping, and sex trade among black South African substance users Substance use and Misuse 45(12): 1971-1987
Chimchang, J.; Theparee, T.; Wongein, S.; Trivirot, T.; Tanasupawa, S.; Taweechotipatr, M.; Wongsatayanon, B. 2016: Screening of Potential Probiotic Lactic Acid Bacteria with Anticancer Properties Journal of the Medical Association of Thailand 99(Suppl 8): S70-S78
Xu, X.; Liu, Z. 1993: Discussion of H substance in urine Journal of Forensic Sciences 38(1): 8-9